Vasculitis & polymyalgia rheumatica

Sex Differences in Clinical Manifestations of Hospitalized Patients With Eosinophilic Granulomatosis With Polyangiitis: A Retrospective Cohort Study

J RheumatolPublished Retrospective cohort study

Authors' conclusion

In this Chinese EGPA cohort, male and female patients showed distinct disease phenotypes. Male patients with EGPA had a higher disease activity at diagnosis and required more aggressive treatment for remission induction.

Study context

Population
Hospitalized patients with eosinophilic granulomatosis with polyangiitis (EGPA) managed at one hospital, 2007–2020, Chinamale to female ratio 1.4:1
Participants
170 patients
Exposure
Male vs female patients with EGPA
Outcome
Clinical manifestations by sex
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

  • Renal involvement (serum creatinine elevation, proteinuria > 1 g/24 h) more frequent in male patients
  • Severe gastrointestinal (GI) involvement more common in male patients
  • Female patients had longer allergy duration and higher ratios of allergic rhinitis and asthma
  • Male patients had higher BVAS and worse prognosis at diagnosis, with lower proportion of 1996 Five Factor Score = 0

Observational data: associations, not effects.

Further findings

Sex differences by age (≤ 55 vs > 55 years)

Sex differences in proteinuria > 1 g/24 h, serum creatinine > 150 mmol/L, severe GI involvement and weight loss more significant in patients aged ≤ 55 years than > 55 years

Treatment selection

Methylprednisolone pulse and CYC administered more frequently to male patients

All-cause mortality and cumulative survival

Comparable between the sexes

Original publication

Sex Differences in Clinical Manifestations of Hospitalized Patients With Eosinophilic Granulomatosis With Polyangiitis: A Retrospective Cohort Study. J Rheumatol. Published 1 June 2023. doi:10.3899/jrheum.2022-1117

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.